Risk of hypoglycemia in Japanese people with type 2 diabetes mellitus who initiated or switched to insulin glargine 300 U/mL: A subgroup analysis of 12-month post-marketing surveillance study (X-STAR study)
Insulin therapy is an established option to improve glycemic control in people with type 2 diabetes (T2D) and, in reality, tends to be reserved for those with advanced stage of diabetes. Insulin is highly efficacious in terms of lowering glucose; however, it imposes potential hypoglycemic risk
Source: Diabetes Research and Clinical Practice - Category: Endocrinology Authors: Takahisa Hirose, Masato Odawara, Munehide Matsuhisa, Ryusuke Koshida, Masayuki Senda, Yasushi Tanaka, Yasuo Terauchi Source Type: research
More News: Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Insulin | Japan Health | Lantus | Marketing | Study